SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-17-000571
Filing Date
2017-04-03
Accepted
2017-04-03 13:43:11
Documents
1
Period of Report
2017-04-01

Document Format Files

Seq Description Document Type Size
1 form4-04032017_100401.html 4  
1 form4-04032017_100401.xml 4 4252
  Complete submission text file 0001415889-17-000571.txt   5681
Mailing Address 38 ANGELL BROOK DRIVE WEST BOYLSTON MA 01853
Business Address
ESBER HENRY JEMIL (Reporting) CIK: 0001391501 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-52991 | Film No.: 17733339

Mailing Address 9171 TOWNE CENTRE DRIVE, SUITE 440 SAN DIEGO CA 92122
Business Address 9171 TOWNE CENTRE DRIVE, SUITE 440 SAN DIEGO CA 92122 858-964-5123
INNOVUS PHARMACEUTICALS, INC. (Issuer) CIK: 0001411879 (see all company filings)

IRS No.: 900814124 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations